Evaluation of bleeding risk in patients exposed to therapeutic unfractionated or low-molecular-weight heparin: a cohort study in the context of a quality improvement initiative.


BACKGROUND Bleeding associated with the use of unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) can be a serious complication of health-care management and should be the focus of quality improvement initiatives by institutions. OBJECTIVE To measure the incidence of bleeding with UFH and LMWH and evaluate associated risk factors… (More)
DOI: 10.1345/aph.1M615


  • Presentations referencing similar topics